Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4100 participants.

Also called NCT06871228

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 4,100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06871228
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06871228. Randomized; single masking; primary purpose treatment. Start 2025-08-05 (actual); primary completion 2029-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
Acronym
DIAMOND-AF
Condition
Atrial Fibrillation (AF)
Intervention (Drug)
NOAC discontinuation
Intervention (Drug)
NOAC continuation
Intervention (Device)
Smartwatch single-lead ECG (electrocardiogram) monitoring
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct06871228
Content hash
27fdbcf2a8da77df1e395d3ab765d0d0f146bc5fd563b6ad9d06f00867f945c9